Table 1. Clinical characteristics and laboratory parameters of csf patients and healthy controls.
| Charactheristics | CSF (n = 33) | Controls (n = 48) | p-value |
| Age (years, mean ± SD) | 55.8 ± 10.3 | 53.9 ± 11.8 | 0.456 |
| Heart rate (bpm) | 69 ± 11 | 69 ± 8 | 0.989 |
| Fasting glucose (mg/dl) | 99 (79–281) | 91 (72–188) | 0.048 |
| LDL cholesterol (mg/dl) | 113 ± 35 | 120 ± 29 | 0.350 |
| HDL cholesterol (mg/dl) | 44 ± 13 | 46 ± 10 | 0.447 |
| BSA (m2) | 1.87 (1.61–2.19) | 1.79 (1.47–2.28) | 0.231 |
| Male, n (%) | 20 (58.8) | 14 (29.8) | 0.009 |
| Hypertension, n (%) | 17 (50) | 25 (53.2) | 0.777 |
| Diabetes mellitus, n (%) | 9 (26.5) | 7 (14.9) | 0.197 |
| Cigarette smoking, n (%) | 9 (26.5) | 12 (25.5) | 0.924 |
| Medications, n (%) | |||
| ACE inhibitor | 12 (35.3) | 12 (25.5) | 0.656 |
| Beta-blocker | 6 (17.6) | 8 (17) | 0.941 |
| Statins | 11 (32.4) | 4 (8.5) | 0.006 |
| Acetyl salicylic acid | 21 (61.8) | 12 (25.5) | 0.001 |
| TIMI frame count | |||
| RCA | 28 (16–38) | 14 (4–22) | 0.001 |
| LCx | 22 (11–40) | 13 (8–21) | 0.001 |
| LAD | 39.5 (22-56) | 18 (10-34) | 0.001 |
| Mean TIMI frame count | 24.2 ± 4 | 13.1 ± 2.5 | 0.001 |
CSF, coronary slow flow; LDL, low-density lipoprotein; HDL, high-density lipoprotein; BSA, body surface area; TIMI, thrombolysis in myocardial infarction; RCA, right coronary artery; LCx, left circumflex artery; LAD, left anterior descending artery; bpm, beats per minute.